7 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 21.9% per year over the past 5 years.
Operating margin has expanded, at 2.2% in the latest year.
Free cash flow has declined 5.9% per year over the past 5 years.
Financial health
The company holds more cash ($39M) than total debt ($25M).
Total debt has grown in line with revenue (-20.3% vs -21.9% per year).
Operating income covered interest expense 1.1× in the latest year, up from -12.0× 5 years ago.
Total debt is 1.8× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$252M
-$3M
73.0%
2.2%
$17M
$25M
$39M
2024
$419M
-$72M
68.6%
-15.8%
-$2M
$22M
$20M
2023
$527M
-$153M
61.3%
-26.7%
-$29M
$35M
$33M
2022
$692M
-$194M
53.4%
-29.3%
-$74M
$49M
$80M
2021
$874M
-$228M
62.4%
-34.0%
-$293M
—
$104M
2020
$864M
-$21M
71.1%
-0.7%
$23M
—
$57M
2019
$756M
$32M
72.2%
2.5%
$18M
—
$42M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$54M
$2M
71.8%
5.7%
-$2M
$25M
$37M
Dec '25
$56M
$5M
74.5%
14.7%
$4M
$25M
$39M
Sep '25
$60M
$4M
74.6%
8.3%
$9M
$25M
$34M
Jun '25
$64M
-$6M
72.3%
-6.2%
$2M
$25M
$26M
Mar '25
$72M
-$6M
71.2%
-5.1%
$2M
$16M
$18M
Dec '24
$86M
-$35M
70.5%
-38.1%
-$7M
$22M
$20M
Sep '24
$102M
-$12M
67.3%
-12.7%
$53000
$25M
$32M
Jun '24
$110M
-$11M
69.3%
-8.6%
-$2M
$25M
$32M
Mar '24
$120M
-$14M
67.7%
-9.0%
$7M
$28M
$39M
Dec '23
$119M
-$65M
62.2%
-50.7%
-$9M
$35M
$33M
Sep '23
$128M
-$33M
58.5%
-22.6%
-$685000
$35M
$38M
Jun '23
$135M
-$26M
61.3%
-17.9%
-$8M
$49M
$59M
Mar '23
$145M
-$29M
63.0%
-18.9%
-$11M
$49M
$66M
Dec '22
$148M
-$45M
57.1%
-32.5%
-$13M
$49M
$80M
Sep '22
$166M
-$34M
63.1%
-21.8%
-$8M
$50M
$94M
Jun '22
$179M
-$42M
48.7%
-24.8%
-$7M
—
$57M
Mar '22
$199M
-$74M
46.8%
-37.4%
-$46M
—
$63M
Dec '21
$216M
-$146M
45.1%
-75.8%
-$93M
—
$104M
Sep '21
$208M
-$40M
64.9%
-34.5%
-$148M
—
$200M
Jun '21
$223M
-$12M
69.2%
-13.5%
-$31M
—
$347M
Valuation over time
How the market has priced BODI against its own fundamentals since 2024-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 0.1× (Mar '24) to 0.3× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is BODI growing its revenue and profit?
Over the past 5 years, Beachbody Company, Inc.'s revenue has declined 21.9% per year. These are computed facts, not advice.
How much debt does BODI have?
As of FY2025, Beachbody Company, Inc. reported $25M of total debt against $39M of cash; operating income covered interest expense 1.1×.
What is BODI's profit margin?
In FY2025, gross margin was 73.0%, operating margin 2.2%, and net margin -1.1%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.